TraumaConnect®: A New Digital Lifeline for Australians Living with Trauma—and the Professionals Who Support Them
MELBOURNE, Australia, May 29, 2025 /PRNewswire/ -- The Cairnmillar Institute is proud to announce the launch of TraumaConnect®, a groundbreaking digital mental health platform designed to support Australians affected by trauma—while also empowering the clinicians, carers, and support workers who walk alongside them. Developed by a team of psychologists, researchers, and people with lived experience, TraumaConnect® is the first...
Innovent Announces a Phase 3 Study of Picankibart (Anti-IL-23p19 Antibody) Completes First Participant Dosing, Exploring Biologics Switching Treatment for Psoriasis Patients with Prior Inadequate Response to Anti-IL-17 Antibodies
SAN FRANCISCO and SUZHOU, China, May 29, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metabolic, ophthalmologic and other major diseases, announces that the first participant has been successfully dosed in a Phase 3 clinical study of picankibart...
Global Experts Warn WHO’s Anti-Harm Reduction Stance Undermines World No Tobacco Day
WASHINGTON, May 29, 2025 /PRNewswire/ -- A panel of global tobacco harm reduction experts convened this week to criticize the World Health Organization (WHO) and the Framework Convention on Tobacco Control (FCTC) Secretariat for undermining the goals of World No Tobacco Day. The group expressed frustration over the WHO's refusal to...
Lunit Launches Enhanced Lunit INSIGHT CXR4, Secures CE MDR Certification for Expanded AI Capabilities
Next-generation AI solution introduces new clinical features and broader disease detection for chest X-rays SEOUL, South Korea, May 28, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, today announced the official launch and CE certification under the Medical Device Regulation (MDR) of Lunit INSIGHT CXR4, its...
Metabolon’s Untargeted Metabolomics Services Used for Landmark Study Linking a Western Dietary Pattern During Pregnancy to Neurodevelopment Disorders
Metabolomic profiling uncovered how maternal diet and metabolism may contribute to the risk of ADHD and autism in children MORRISVILLE, N.C., May 28, 2025 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision...
Long-term Commitment to Treating Endometriosis and Improving Women’s Quality of Life – Gedeon Richter at the World Congress on Endometriosis
SYDNEY, May 28, 2025 /PRNewswire/ --Gedeon Richter had a strong presence at the World Congress of Endometriosis held this year in Sydney, Australia between 21-24 May 2025. As a Platinum Sponsor Gedeon Richter could reaffirm its innovation driven and long-term commitment in the field of endometriosis and in women's health....
Formosa Pharmaceuticals and Adalvo Limited Announce Licensing Agreement for Clobetasol Propionate Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain
TAIPEI, May 28, 2025 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced that the company has entered into an exclusive licensing agreement with Adalvo Limited ("Adalvo") in the European and Brazilian markets for exclusive rights to the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a marketed innovative treatment of post-operative inflammation...
IonOpticks Generation 4 Aurora Series® sets a new benchmark in chromatography
MELBOURNE, Australia, May 28, 2025 /PRNewswire/ -- IonOpticks, developer of the highest-performing chromatography columns for mass spectrometry research, today announces the launch of its 4th Generation of Aurora Series columns. Following extensive testing by leading proteomics researchers, the latest generation further strengthens the qualities that made the Aurora Series® famous, offering enhanced robustness, longevity, spray stability and reproducibility, while...
NX China Acquires GDP Certification for Shanghai and Lianyungang Facilities
- Establishing High-quality Pharmaceutical Logistics Service Systems - TOKYO, May 28, 2025 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereafter "NX China"), a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution Practice (GDP) certification for air and ocean freight forwarding of pharmaceutical products at facilities in Shanghai and Lianyungang, Jiangsu Province, effective Friday, February...
EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
PROVIDENCE, R.I., May 28, 2025 /PRNewswire/ -- EpiVax, Inc., a leader in preclinical immunogenicity assessment for biologic therapeutics and vaccines, is pleased to announce the appointment of Vibha Jawa, PhD, FAAPS as Chief Scientific Officer. Dr. Jawa succeeds EpiVax founder and Executive Chairwoman Annie De Groot, MD, who has transitioned from...
